Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 839

1.

Reducing Overtreatment of Cancer With Precision Medicine: Just What the Doctor Ordered.

Katz SJ, Jagsi R, Morrow M.

JAMA. 2018 Feb 22. doi: 10.1001/jama.2018.0018. [Epub ahead of print] No abstract available.

PMID:
29470568
2.

Patient Experiences and Clinician Views on the Role of Radiation Therapy for Ductal Carcinoma In Situ.

Shumway DA, McLeod CM, Morrow M, Li Y, Kurian AW, Sabolch A, Hamilton AS, Ward KC, Katz SJ, Hawley ST, Jagsi R.

Int J Radiat Oncol Biol Phys. 2018 Jan 9. pii: S0360-3016(18)30058-0. doi: 10.1016/j.ijrobp.2018.01.020. [Epub ahead of print]

PMID:
29439886
3.

Trend Analysis on Reoperation After Lumpectomy for Breast Cancer-Reply.

Morrow M, Abrahamse P, Katz SJ.

JAMA Oncol. 2018 Feb 8. doi: 10.1001/jamaoncol.2017.5261. [Epub ahead of print] No abstract available.

PMID:
29423506
4.

Reversible Control of Network Properties in Azobenzene-Containing Hyaluronic Acid-Based Hydrogels.

Rosales AM, Rodell CB, Chen MH, Morrow MG, Anseth KS, Burdick JA.

Bioconjug Chem. 2018 Feb 19. doi: 10.1021/acs.bioconjchem.7b00802. [Epub ahead of print]

PMID:
29406696
5.

Conceptualizing depression in Vietnam: Primary health care providers' explanatory models of depression.

Murphy J, Goldner E, Corbett KK, Morrow M, Nguyen VC, Linh DT, Oanh PT.

Transcult Psychiatry. 2018 Jan 1:1363461517748846. doi: 10.1177/1363461517748846. [Epub ahead of print]

PMID:
29405843
6.

Preadolescents' Daily Peer Victimization and Perceived Social Competence: Moderating Effects of Classroom Aggression.

Morrow MT, Hubbard JA, Sharp MK.

J Clin Child Adolesc Psychol. 2018 Jan 29:1-12. doi: 10.1080/15374416.2017.1416618. [Epub ahead of print]

PMID:
29377725
7.

Improving Breast Cancer Surgical Treatment Decision Making: The iCanDecide Randomized Clinical Trial.

Hawley ST, Li Y, An LC, Resnicow K, Janz NK, Sabel MS, Ward KC, Fagerlin A, Morrow M, Jagsi R, Hofer TP, Katz SJ.

J Clin Oncol. 2018 Jan 24:JCO2017748442. doi: 10.1200/JCO.2017.74.8442. [Epub ahead of print]

PMID:
29364772
8.

Higher Art Adherence is Associated with Lower Systemic Inflammation in Treatment-Naïve Ugandans Who Achieve Virologic Suppression.

Castillo-Mancilla JR, Morrow M, Boum Y, Byakwaga H, Haberer JE, Martin JN, Bangsberg D, Mawhinney S, Musinguzi N, Huang Y, Tracy RP, Burdo TH, Williams K, Muzoora C, Hunt PW, Siedner MJ.

J Acquir Immune Defic Syndr. 2018 Jan 16. doi: 10.1097/QAI.0000000000001629. [Epub ahead of print]

PMID:
29346185
9.

Margins in breast cancer: How much is enough?

Pilewskie M, Morrow M.

Cancer. 2018 Jan 16. doi: 10.1002/cncr.31221. [Epub ahead of print] Review.

PMID:
29338088
10.

Breast carcinoma with 21-gene recurrence score lower than 18: rate of locoregional recurrence in a large series with clinical follow-up.

Turashvili G, Brogi E, Morrow M, Dickler M, Norton L, Hudis C, Wen HY.

BMC Cancer. 2018 Jan 6;18(1):42. doi: 10.1186/s12885-017-3985-y.

11.

In vivo protection against ZIKV infection and pathogenesis through passive antibody transfer and active immunisation with a prMEnv DNA vaccine.

Muthumani K, Griffin BD, Agarwal S, Kudchodkar SB, Reuschel EL, Choi H, Kraynyak KA, Duperret EK, Keaton AA, Chung C, Kim YK, Booth SA, Racine T, Yan J, Morrow MP, Jiang J, Lee B, Ramos S, Broderick KE, Reed CC, Khan AS, Humeau L, Ugen KE, Park YK, Maslow JN, Sardesai NY, Joseph Kim J, Kobinger GP, Weiner DB.

NPJ Vaccines. 2016 Nov 10;1:16021. doi: 10.1038/npjvaccines.2016.21. eCollection 2016.

12.

Management of the Node-Positive Axilla in Breast Cancer in 2017: Selecting the Right Option.

Morrow M.

JAMA Oncol. 2018 Feb 1;4(2):250-251. doi: 10.1001/jamaoncol.2017.3625. No abstract available.

PMID:
29242929
13.

In Nurses We Trust.

Morrow MR.

Nurs Sci Q. 2018 Jan;31(1):95-96. doi: 10.1177/0894318417741096. No abstract available.

PMID:
29235945
14.

Brief Report: Adherence Biomarker Measurements in Older and Younger HIV-Infected Adults Receiving Tenofovir-Based Therapy.

Seifert SM, Castillo-Mancilla JR, Erlandson K, Morrow M, Gandhi M, Kuncze K, Horng H, Zheng JH, Bushman LR, Kiser JJ, MaWhinney S, Anderson PL.

J Acquir Immune Defic Syndr. 2018 Mar 1;77(3):295-298. doi: 10.1097/QAI.0000000000001596.

PMID:
29189417
15.

Confusion Over Differences in Registration and Randomization Criteria for the LORIS (Low-Risk DCIS) Trial: A Reply.

Pilewskie M, Van Zee KJ, Morrow M.

Ann Surg Oncol. 2017 Dec;24(Suppl 3):568-569. doi: 10.1245/s10434-017-6175-x. Epub 2017 Nov 16. No abstract available.

PMID:
29147925
16.

Teacher factors contributing to dosage of the KiVa anti-bullying program.

Swift LE, Hubbard JA, Bookhout MK, Grassetti SN, Smith MA, Morrow MT.

J Sch Psychol. 2017 Dec;65:102-115. doi: 10.1016/j.jsp.2017.07.005. Epub 2017 Aug 29.

PMID:
29145938
17.

XtalFluor-E® mediated proto-functionalization of N-vinyl amides: access to N-acetyl N,O-acetals.

Yi Y, Gholami H, Morrow MG, Borhan B.

Org Biomol Chem. 2017 Nov 22;15(45):9570-9574. doi: 10.1039/c7ob02283b.

PMID:
29106419
18.

Leptin regulation of the p53-HIF1α/PKM2-aromatase axis in breast adipose stromal cells: a novel mechanism for the obesity-breast cancer link.

Zahid H, Subbaramaiah K, Iyengar NM, Zhou XK, Chen IC, Bhardwaj P, Gucalp A, Morrow M, Hudis CA, Dannenberg AJ, Brown KA.

Int J Obes (Lond). 2017 Nov 6. doi: 10.1038/ijo.2017.273. [Epub ahead of print]

PMID:
29104286
19.

Broad cross-protective anti-hemagglutination responses elicited by influenza microconsensus DNA vaccine.

Yan J, Morrow MP, Chu JS, Racine T, Reed CC, Khan AS, Broderick KE, Kim JJ, Kobinger GP, Sardesai NY, Weiner DB.

Vaccine. 2017 Oct 31. pii: S0264-410X(17)31358-0. doi: 10.1016/j.vaccine.2017.09.086. [Epub ahead of print]

PMID:
29100705
20.

Clinical and Immunologic Biomarkers for Histologic Regression of High-Grade Cervical Dysplasia and Clearance of HPV16 and HPV18 after Immunotherapy.

Morrow MP, Kraynyak KA, Sylvester AJ, Dallas M, Knoblock D, Boyer JD, Yan J, Vang R, Khan AS, Humeau L, Sardesai NY, Kim JJ, Plotkin S, Weiner DB, Trimble CL, Bagarazzi ML.

Clin Cancer Res. 2018 Jan 15;24(2):276-294. doi: 10.1158/1078-0432.CCR-17-2335. Epub 2017 Oct 30.

PMID:
29084917
21.

Reply to 'The St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017: the point of view of an International Panel of Experts in Radiation Oncology' by Kirova et al.

Dubsky P, Curigliano G, Burstein HJ, Winer EP, Gnant M, Loibl S, Colleoni M, Regan MM, Piccart-Gebhart M, Senn HJ, Thürlimann B; Panel Members of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017, André F, Baselga J, Bergh J, Bonnefoi H, Brucker SY, Cardoso F, Carey L, Ciruelos E, Cuzick J, Denkert C, Di Leo A, Ejlertsen B, Francis P, Galimberti V, Garber J, Gulluoglu B, Goodwin P, Harbeck N, Hayes DF, Huang CS, Huober J, Khaled H, Jassem J, Jiang Z, Karlsson P, Morrow M, Orecchia R, Osborne KC, Pagani O, Partridge AH, Pritchard K, Ro J, Rutgers EJT, Sedlmayer F, Semiglazov V, Shao Z, Smith I, Toi M, Tutt A, Viale G, Watanabe T, Whelan TJ, Xu B.

Ann Oncol. 2018 Jan 1;29(1):281-282. doi: 10.1093/annonc/mdx543. No abstract available.

PMID:
29045519
22.

Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots following Directly Observed Therapy.

Anderson PL, Liu AY, Castillo-Mancilla JR, Gardner EM, Seifert SM, McHugh C, Wagner T, Campbell K, Morrow M, Ibrahim M, Buchbinder S, Bushman LR, Kiser JJ, MaWhinney S.

Antimicrob Agents Chemother. 2017 Dec 21;62(1). pii: e01710-17. doi: 10.1128/AAC.01710-17. Print 2018 Jan.

PMID:
29038282
23.

Treatment decisions and employment of breast cancer patients: Results of a population-based survey.

Jagsi R, Abrahamse PH, Lee KL, Wallner LP, Janz NK, Hamilton AS, Ward KC, Morrow M, Kurian AW, Friese CR, Hawley ST, Katz SJ.

Cancer. 2017 Dec 15;123(24):4791-4799. doi: 10.1002/cncr.30959. Epub 2017 Oct 9.

PMID:
28990155
24.

Contralateral Prophylactic Mastectomy.

Ramaswami R, Morrow M, Jagsi R.

N Engl J Med. 2017 Sep 28;377(13):1288-1291. doi: 10.1056/NEJMclde1708293. No abstract available.

25.

Integrating Function-Directed Treatments into Palliative Care.

Cheville AL, Morrow M, Smith SR, Basford JR.

PM R. 2017 Sep;9(9S2):S335-S346. doi: 10.1016/j.pmrj.2017.07.073. Review.

PMID:
28942908
26.

Contralateral breast cancers: Independent cancers or metastases?

Begg CB, Ostrovnaya I, Geyer FC, Papanastasiou AD, Ng CKY, Sakr RA, Bernstein JL, Burke KA, King TA, Piscuoglio S, Mauguen A, Orlow I, Weigelt B, Seshan VE, Morrow M, Reis-Filho JS.

Int J Cancer. 2018 Jan 15;142(2):347-356. doi: 10.1002/ijc.31051. Epub 2017 Sep 28.

PMID:
28921573
27.

MRI and Prediction of Pathologic Complete Response in the Breast and Axilla after Neoadjuvant Chemotherapy for Breast Cancer.

Weber JJ, Jochelson MS, Eaton A, Zabor EC, Barrio AV, Gemignani ML, Pilewskie M, Van Zee KJ, Morrow M, El-Tamer M.

J Am Coll Surg. 2017 Dec;225(6):740-746. doi: 10.1016/j.jamcollsurg.2017.08.027. Epub 2017 Sep 15.

PMID:
28919579
28.

Tumor Biology Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients Presenting with Locally Advanced Breast Cancer.

Gentile LF, Plitas G, Zabor EC, Stempel M, Morrow M, Barrio AV.

Ann Surg Oncol. 2017 Dec;24(13):3896-3902. doi: 10.1245/s10434-017-6085-y. Epub 2017 Sep 15.

PMID:
28916978
29.

Applying the Care Group model to tuberculosis control: findings from a community-based project in Mozambique.

Brown A, Ernst P, Cambule A, Morrow M, Dortzbach D, Golub JE, Perry HB.

Int J Tuberc Lung Dis. 2017 Oct 1;21(10):1086-1093. doi: 10.5588/ijtld.17.0179.

PMID:
28911350
30.

Surgeon Influence on Variation in Receipt of Contralateral Prophylactic Mastectomy for Women With Breast Cancer.

Katz SJ, Hawley ST, Hamilton AS, Ward KC, Morrow M, Jagsi R, Hofer TP.

JAMA Surg. 2018 Jan 1;153(1):29-36. doi: 10.1001/jamasurg.2017.3415.

PMID:
28903158
31.

Pedagogical Approaches to Teaching-Learning Theory.

Morrow MR.

Nurs Sci Q. 2017 Jan;30(1):81-82. doi: 10.1177/0894318416680712. No abstract available.

PMID:
28899287
32.

More Questions.

Morrow MR.

Nurs Sci Q. 2017 Jul;30(3):277. doi: 10.1177/0894318417708425. No abstract available.

PMID:
28899279
33.

Shedding Light for Future Generations.

Morrow MR.

Nurs Sci Q. 2017 Apr;30(2):182. doi: 10.1177/0894318417693315. No abstract available.

PMID:
28899248
34.

Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.

Giuliano AE, Ballman KV, McCall L, Beitsch PD, Brennan MB, Kelemen PR, Ollila DW, Hansen NM, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, Hunt KK, Morrow M.

JAMA. 2017 Sep 12;318(10):918-926. doi: 10.1001/jama.2017.11470.

35.

CMA analysis identifies homozygous deletion of MCPH1 in 2 brothers with primary Microcephaly-1.

Hemmat M, Rumple MJ, Mahon LW, Morrow M, Zach T, Anguiano A, Elnaggar MM, Wang BT, Boyar FZ.

Mol Cytogenet. 2017 Sep 5;10:33. doi: 10.1186/s13039-017-0334-4. eCollection 2017.

36.

Magnetic Resonance Imaging of Musculoskeletal Emergencies.

Mehta P, Morrow M, Russell J, Madhuripan N, Habeeb M.

Semin Ultrasound CT MR. 2017 Aug;38(4):439-452. doi: 10.1053/j.sult.2017.04.001. Epub 2017 Apr 5.

PMID:
28865532
37.

Imaging of Female Pelvic Emergencies.

Thut DP, Morrow MS, Moore CC.

Semin Ultrasound CT MR. 2017 Aug;38(4):310-326. doi: 10.1053/j.sult.2017.02.001. Epub 2017 Feb 20.

PMID:
28865523
38.

Should Oral Corticosteroids Be Used to Treat Demyelinating Optic Neuritis?

Morrow MJ, Ko MW.

J Neuroophthalmol. 2017 Dec;37(4):444-450. doi: 10.1097/WNO.0000000000000555. No abstract available.

PMID:
28857910
39.

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.

Curigliano G, Burstein HJ, P Winer E, Gnant M, Dubsky P, Loibl S, Colleoni M, Regan MM, Piccart-Gebhart M, Senn HJ, Thürlimann B; St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017, André F, Baselga J, Bergh J, Bonnefoi H, Y Brucker S, Cardoso F, Carey L, Ciruelos E, Cuzick J, Denkert C, Di Leo A, Ejlertsen B, Francis P, Galimberti V, Garber J, Gulluoglu B, Goodwin P, Harbeck N, Hayes DF, Huang CS, Huober J, Hussein K, Jassem J, Jiang Z, Karlsson P, Morrow M, Orecchia R, Osborne KC, Pagani O, Partridge AH, Pritchard K, Ro J, Rutgers EJT, Sedlmayer F, Semiglazov V, Shao Z, Smith I, Toi M, Tutt A, Viale G, Watanabe T, Whelan TJ, Xu B.

Ann Oncol. 2017 Aug 1;28(8):1700-1712. doi: 10.1093/annonc/mdx308.

PMID:
28838210
40.

Divide & Conquer: Surfactant Protein SP-C and Cholesterol Modulate Phase Segregation in Lung Surfactant.

Roldan N, Pérez-Gil J, Morrow MR, García-Álvarez B.

Biophys J. 2017 Aug 22;113(4):847-859. doi: 10.1016/j.bpj.2017.06.059.

PMID:
28834721
41.

Outcomes for Women with Minimal-Volume Ductal Carcinoma In Situ Completely Excised at Core Biopsy.

Muhsen S, Barrio AV, Miller M, Olcese C, Patil S, Morrow M, Van Zee KJ.

Ann Surg Oncol. 2017 Dec;24(13):3888-3895. doi: 10.1245/s10434-017-6043-8. Epub 2017 Aug 21.

PMID:
28828599
42.

The association between patient attitudes and values and the strength of consideration for contralateral prophylactic mastectomy in a population-based sample of breast cancer patients.

Hawley ST, Griffith KA, Hamilton AS, Ward KC, Morrow M, Janz NK, Katz SJ, Jagsi R.

Cancer. 2017 Dec 1;123(23):4547-4555. doi: 10.1002/cncr.30924. Epub 2017 Aug 15.

PMID:
28810062
43.

Contralateral Breast Cancer Risk in Women with Ductal Carcinoma In Situ: Is it High Enough to Justify Bilateral Mastectomy?

Miller ME, Muhsen S, Olcese C, Patil S, Morrow M, Van Zee KJ.

Ann Surg Oncol. 2017 Oct;24(10):2889-2897. doi: 10.1245/s10434-017-5931-2. Epub 2017 Aug 1.

PMID:
28766208
44.

The Optimal Treatment Plan to Avoid Axillary Lymph Node Dissection in Early-Stage Breast Cancer Patients Differs by Surgical Strategy and Tumor Subtype.

Pilewskie M, Zabor EC, Mamtani A, Barrio AV, Stempel M, Morrow M.

Ann Surg Oncol. 2017 Nov;24(12):3527-3533. doi: 10.1245/s10434-017-6016-y. Epub 2017 Jul 31.

PMID:
28762114
45.

Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population.

Reiner AS, Lynch CF, Sisti JS, John EM, Brooks JD, Bernstein L, Knight JA, Hsu L, Concannon P, Mellemkjær L, Tischkowitz M, Haile RW, Shen R, Malone KE, Woods M, Liang X, Morrow M, Bernstein JL; WECARE Study Collaborative Group.

Breast Cancer Res. 2017 Jul 19;19(1):83. doi: 10.1186/s13058-017-0874-x.

46.

Erratum to: Axillary Micrometastases and Isolated Tumor Cells Are Not an Indication for Post-mastectomy Radiotherapy in Stage 1 and 2 Breast Cancer.

Mamtani A, Patil S, Stempel M, Morrow M.

Ann Surg Oncol. 2017 Dec;24(Suppl 3):691-692. doi: 10.1245/s10434-017-6004-2. No abstract available.

PMID:
28718032
47.

21-Gene recurrence score and locoregional recurrence in lymph node-negative, estrogen receptor-positive breast cancer.

Turashvili G, Chou JF, Brogi E, Morrow M, Dickler M, Norton L, Hudis C, Wen HY.

Breast Cancer Res Treat. 2017 Nov;166(1):69-76. doi: 10.1007/s10549-017-4381-7. Epub 2017 Jul 12.

48.

Oncologic Outcomes After Treatment for MRI Occult Breast Cancer (pT0N+).

McCartan DP, Zabor EC, Morrow M, Van Zee KJ, El-Tamer MB.

Ann Surg Oncol. 2017 Oct;24(11):3141-3147. doi: 10.1245/s10434-017-5965-5. Epub 2017 Jul 12.

PMID:
28702770
49.

De-escalating and escalating surgery in the management of early breast cancer.

Morrow M.

Breast. 2017 Aug;34 Suppl 1:S1-S4. doi: 10.1016/j.breast.2017.06.018. Epub 2017 Jun 30.

PMID:
28673537
50.

Institutionalizing community-focused maternal, newborn, and child health strategies to strengthen health systems: A new framework for the Sustainable Development Goal era.

Story WT, LeBan K, Altobelli LC, Gebrian B, Hossain J, Lewis J, Morrow M, Nielsen JN, Rosales A, Rubardt M, Shanklin D, Weiss J.

Global Health. 2017 Jun 26;13(1):37. doi: 10.1186/s12992-017-0259-z.

Supplemental Content

Loading ...
Support Center